Literature DB >> 16162501

Loss of editing activity during the evolution of mitochondrial phenylalanyl-tRNA synthetase.

Hervé Roy1, Jiqiang Ling, Juan Alfonzo, Michael Ibba.   

Abstract

Accurate selection of amino acids is essential for faithful translation of the genetic code. Errors during amino acid selection are usually corrected by the editing activity of aminoacyl-tRNA synthetases such as phenylalanyl-tRNA synthetases (PheRS), which edit misactivated tyrosine. Comparison of cytosolic and mitochondrial PheRS from the yeast Saccharomyces cerevisiae suggested that the organellar protein might lack the editing activity. Yeast cytosolic PheRS was found to contain an editing site, which upon disruption abolished both cis and trans editing of Tyr-tRNA(Phe). Wild-type mitochondrial PheRS lacked cis and trans editing and could synthesize Tyr-tRNA(Phe), an activity enhanced in active site variants with improved tyrosine recognition. Possible trans editing was investigated in isolated mitochondrial extracts, but no such activity was detected. These data indicate that the mitochondrial protein synthesis machinery lacks the tyrosine proofreading activity characteristic of cytosolic translation. This difference between the mitochondria and the cytosol suggests that either organellar protein synthesis quality control is focused on another step or that translation in this compartment is inherently less accurate than in the cytosol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162501     DOI: 10.1074/jbc.M508281200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Cellular mechanisms that control mistranslation.

Authors:  Noah M Reynolds; Beth A Lazazzera; Michael Ibba
Journal:  Nat Rev Microbiol       Date:  2010-12       Impact factor: 60.633

2.  The mechanism of pre-transfer editing in yeast mitochondrial threonyl-tRNA synthetase.

Authors:  Jiqiang Ling; Kaitlyn M Peterson; Ivana Simonovic; Dieter Söll; Miljan Simonovic
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

3.  Degenerate connective polypeptide 1 (CP1) domain from human mitochondrial leucyl-tRNA synthetase.

Authors:  Qing Ye; Meng Wang; Zhi-Peng Fang; Zhi-Rong Ruan; Quan-Quan Ji; Xiao-Long Zhou; En-Duo Wang
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

4.  Aminoacylation of tRNA 2'- or 3'-hydroxyl by phosphoseryl- and pyrrolysyl-tRNA synthetases.

Authors:  Markus Englert; Sarath Moses; Michael Hohn; Jiqiang Ling; Patrick O'Donoghue; Dieter Söll
Journal:  FEBS Lett       Date:  2013-09-08       Impact factor: 4.124

5.  [3'-32P]-labeling tRNA with nucleotidyltransferase for assaying aminoacylation and peptide bond formation.

Authors:  Sarah Ledoux; Olke C Uhlenbeck
Journal:  Methods       Date:  2008-02       Impact factor: 3.608

Review 6.  The return of pretransfer editing in protein synthesis.

Authors:  Srujana S Yadavalli; Karin Musier-Forsyth; Michael Ibba
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-04       Impact factor: 11.205

7.  Isoacceptor specific characterization of tRNA aminoacylation and misacylation in vivo.

Authors:  Kyle Mohler; Rebecca Mann; Michael Ibba
Journal:  Methods       Date:  2016-09-14       Impact factor: 3.608

8.  Purification, crystallization and preliminary X-ray characterization of a human mitochondrial phenylalanyl-tRNA synthetase.

Authors:  Inna Levin; Naama Kessler; Nina Moor; Liron Klipcan; Emine Koc; Paul Templeton; Linda Spremulli; Mark Safro
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-25

9.  Discrimination of cognate and noncognate substrates at the active site of class I lysyl-tRNA synthetase.

Authors:  Shiming Wang; Mette Praetorius-Ibba; Sandro F Ataide; Hervé Roy; Michael Ibba
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

10.  Do anticodons of misacylated tRNAs preferentially mismatch codons coding for the misloaded amino acid?

Authors:  Hervé Seligmann
Journal:  BMC Mol Biol       Date:  2010-05-28       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.